Repositorio Dspace

Prognostic impact of variant allele frequency in intensively treated patients with NPM1-mutated AML: a PETHEMA study

Mostrar el registro sencillo del ítem

dc.contributor.author Gil, José-Vicente
dc.contributor.author Sargas, Claudia
dc.contributor.author Ayala, Rosa
dc.contributor.author Gutiérrez, Norma-Carmen
dc.contributor.author Pérez-Simon, José-Antonio
dc.contributor.author Gómez-Casares, María-Teresa
dc.contributor.author Larrayoz, María-José
dc.contributor.author Prados, Esther
dc.contributor.author Cano-Ferri, Isabel
dc.contributor.author Navarro, Irene
dc.contributor.author Gil, Cristina
dc.contributor.author Bernal, Teresa
dc.contributor.author Rodríguez-Arboli, Eduardo
dc.contributor.author Pérez-Santaolalla, Esther
dc.contributor.author Colmenares, Rafael
dc.contributor.author Tormo, Mar
dc.contributor.author Bergua, Juan
dc.contributor.author Amigo, María-Luz
dc.contributor.author Rodríguez-Medina, Carlos
dc.contributor.author Serrano, Josefina
dc.contributor.author Oliva, Ana-Yurena
dc.contributor.author Alonso-Domínguez, Juan-Manuel
dc.contributor.author Noriega, Victor
dc.contributor.author Algarra, Lorenzo
dc.contributor.author Olave, Mayte
dc.contributor.author García-Pérez, María-José
dc.contributor.author Couto, Carmen
dc.contributor.author Almela, Agata
dc.contributor.author García-Fortes, María
dc.contributor.author Madrigal, María-Dolores
dc.contributor.author Hermosin, María-Lourdes
dc.contributor.author Colorado, Mercedes
dc.contributor.author García-Boyero, Raimundo
dc.contributor.author Ibanez, Francisco
dc.contributor.author Sole, María
dc.contributor.author Martínez-Chamorro, Carmen
dc.contributor.author Mateos, María-del-Carmen
dc.contributor.author García-Garay, María-Carmen
dc.contributor.author Solana-Altabella, Antonio
dc.contributor.author Martin-Herreros, Beatriz
dc.contributor.author Martínez-López, Joaquin
dc.contributor.author Chillon, María-del-Carmen
dc.contributor.author Soria, Elena
dc.contributor.author Bilbao-Syeiro, Cristina
dc.contributor.author Calasanz, María-José
dc.contributor.author Sánchez-García, Joaquin
dc.contributor.author Barragan, Eva
dc.contributor.author Montesinos, Pau
dc.date.accessioned 2026-11-11T09:07:21Z
dc.date.available 2026-11-11T09:07:21Z
dc.date.issued 2026-10-08
dc.identifier.citation Gil JV, Sargas C, Ayala R, Gutiérrez NC, Pérez-Simón JA, Gómez-Casares MT, et al. Prognostic impact of variant allele frequency in intensively treated patients with NPM1 -mutated AML: a PETHEMA study. Blood. 8 de octubre de 2026;148(15):1911-24. doi:10.1182/blood.2026033576
dc.identifier.issn 0006-4971
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/29206
dc.description.abstract NPM1-mutated acute myeloid leukemia (AML) is genetically well defined, but clinical outcomes remain heterogeneous, suggesting that quantitative clonal features may refine current risk stratification. We analyzed 688 intensively treated NPM1-mutated (NPM1mut) AML integrating variant allele frequency (VAF), mutation order, and clonal architecture inferred by PyClone and ClonEvol. Comutations were present in 97% of patients (median, 3 per case), dominated by DNMT3A (49%), FLT3-ITD (46%), TET2 (22%), and IDH2 (20%). Prognostic modeling of NPM1 VAF identified an optimal cutoff of 31.44%, defining NPM1high and NPM1low groups. NPM1low correlated with splicing-related alterations and independently predicted inferior overall survival (hazard ratio [HR], 1.46; P = .037) and relapse-free survival (HR, 1.40; P = .036). Gene-specific VAF analyses revealed divergent effects across partners: high DNMT3A, FLT3-OTHER (non-ITD/TKD), KRAS, and PTPN11 burdens were adverse, whereas high IDH2 VAF was protective. Combined models showed that patients with NPM1high and favorable comutation VAFs had the best outcomes, whereas dual unfavorable burdens conferred the poorest survival. Mutation ordering inferred from VAFs positioned NPM1 after epigenetic and splicing lesions but before signaling and transcription-factor mutations. Noncanonical orders, such as early FLT3-OTHER/TKD or WT1 before NPM1, significantly stratified outcomes. Clonal reconstruction revealed predominantly linear evolutionary trajectories (84.3%), with increased mutational burden and clonal diversity associating with inferior survival. Notably, intraclonal colocalization of NPM1 with IDH1 or TET2 was associated with improved outcomes, whereas colocalization with WT1 predicted dismal prognosis. These results demonstrate that quantitative and structural dimensions of clonality refine the biological and prognostic landscape of NPM1-mutated AML beyond mutational status alone.
dc.language.iso eng
dc.publisher ELSEVIER
dc.rights Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es *
dc.subject.mesh Humans
dc.subject.mesh Nucleophosmin
dc.subject.mesh Leukemia, Myeloid, Acute/genetics/mortality/therapy/diagnosis/drug therapy
dc.subject.mesh Mutation
dc.subject.mesh Prognosis
dc.subject.mesh Nuclear Proteins/genetics
dc.subject.mesh Gene Frequency
dc.subject.mesh Female
dc.subject.mesh Male
dc.subject.mesh Middle Aged
dc.subject.mesh Aged
dc.title Prognostic impact of variant allele frequency in intensively treated patients with NPM1-mutated AML: a PETHEMA study
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 42258402
dc.relation.publisherversion https://ashpublications.org/blood/article/148/15/1911/568987/Prognostic-impact-of-variant-allele-frequency-in
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.1182/blood.2026033576
dc.journal.title Blood
dc.identifier.essn 1528-0020


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta